Cypress Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,440
| Closed | -$439K | – | 117 |
|
|
2023
Q3 | $439K | Sell |
13,440
-12,355
| -48% | -$437K | 0.15% | 90 |
|
|
2023
Q2 | $946K | Sell |
25,795
-12,953
| -33% | -$504K | 0.3% | 76 |
|
|
2023
Q1 | $1.58M | Sell |
38,748
-3,929
| -9% | -$170K | 0.55% | 53 |
|
|
2022
Q4 | $2.19M | Sell |
42,677
-1,425
| -3% | -$68.3K | 0.79% | 41 |
|
|
2022
Q3 | $1.93M | Sell |
44,102
-955
| -2% | -$46.4K | 0.74% | 43 |
|
|
2022
Q2 | $2.36M | Sell |
45,057
-1,300
| -3% | -$66.2K | 0.84% | 41 |
|
|
2022
Q1 | $2.4M | Sell |
46,357
-9,343
| -17% | -$485K | 0.7% | 46 |
|
|
2021
Q4 | $3.29M | Buy |
55,700
+5,252
| +10% | +$260K | 0.78% | 41 |
|
|
2021
Q3 | $2.17M | Sell |
50,448
-121
| -0.2% | -$5.36K | 0.56% | 58 |
|
|
2021
Q2 | $1.98M | Sell |
50,569
-1,500
| -3% | -$58.3K | 0.51% | 61 |
|
|
2021
Q1 | $1.89M | Sell |
52,069
-1,539
| -3% | -$54.6K | 0.52% | 63 |
|
|
2020
Q4 | $1.97M | Sell |
53,608
-3,269
| -6% | -$120K | 0.55% | 61 |
|
|
2020
Q3 | $1.98M | Sell |
56,877
-749
| -1% | -$26.3K | 0.62% | 57 |
|
|
2020
Q2 | $1.79M | Buy |
57,626
+442
| +0.8% | +$15K | 0.6% | 58 |
|
|
2020
Q1 | $1.77M | Buy |
57,184
+207
| +0.4% | +$7.05K | 0.76% | 46 |
|
|
2019
Q4 | $2.12M | Sell |
56,977
-1,984
| -3% | -$70.7K | 0.72% | 44 |
|
|
2019
Q3 | $2.01M | Sell |
58,961
-537
| -0.9% | -$19.5K | 0.7% | 50 |
|
|
2019
Q2 | $2.44M | Sell |
59,498
-369
| -0.6% | -$14.7K | 0.84% | 38 |
|
|
2019
Q1 | $2.41M | Sell |
59,867
-475
| -0.8% | -$19K | 0.82% | 38 |
|
|
2018
Q4 | $2.5M | Sell |
60,342
-1,942
| -3% | -$80.6K | 0.93% | 34 |
|
|
2018
Q3 | $2.6M | Sell |
62,284
-1,623
| -3% | -$62.5K | 0.76% | 43 |
|
|
2018
Q2 | $2.2M | Sell |
63,907
-6,403
| -9% | -$219K | 0.65% | 50 |
|
|
2018
Q1 | $2.37M | Sell |
70,310
-10,145
| -13% | -$349K | 0.69% | 51 |
|
|
2017
Q4 | $2.77M | Sell |
80,455
-6,714
| -8% | -$229K | 0.59% | 55 |
|
|
2017
Q3 | $2.95M | Sell |
87,169
-1,924
| -2% | -$61.8K | 0.64% | 53 |
|
|
2017
Q2 | $2.84M | Sell |
89,093
-163,599
| -65% | -$5.16M | 0.58% | 56 |
|
|
2017
Q1 | $8.2M | Sell |
252,692
-10,722
| -4% | -$338K | 1.57% | 16 |
|
|
2016
Q4 | $8.12M | Buy |
263,414
+1,806
| +0.7% | +$55.1K | 1.56% | 16 |
|
|
2016
Q3 | $8.41M | Sell |
261,608
-2,498
| -0.9% | -$83.5K | 1.68% | 16 |
|
|
2016
Q2 | $8.82M | Sell |
264,106
-2,399
| -0.9% | -$76.6K | 1.75% | 16 |
|
|
2016
Q1 | $7.5M | Sell |
266,505
-1,887
| -0.7% | -$53.9K | 1.52% | 18 |
|
|
2015
Q4 | $8.22M | Buy |
268,392
+728
| +0.3% | +$22.9K | 1.65% | 16 |
|
|
2015
Q3 | $7.98M | Sell |
267,664
-633
| -0.2% | -$20.3K | 1.68% | 15 |
|
|
2015
Q2 | $8.54M | Buy |
268,297
+2,678
| +1% | +$87.3K | 1.6% | 16 |
|
|
2015
Q1 | $8.77M | Sell |
265,619
-6,007
| -2% | -$191K | 1.64% | 17 |
|
|
2014
Q4 | $8.03M | Buy |
271,626
+4,700
| +2% | +$135K | 1.48% | 22 |
|
|
2014
Q3 | $7.49M | Sell |
266,926
-3,003
| -1% | -$84.3K | 1.35% | 22 |
|
|
2014
Q2 | $7.6M | Sell |
269,929
-927
| -0.3% | -$26.4K | 1.31% | 22 |
|
|
2014
Q1 | $8.25M | Sell |
270,856
-5,684
| -2% | -$169K | 1.5% | 20 |
|
|
2013
Q4 | $8.04M | Buy |
276,540
+122,850
| +80% | +$3.58M | 1.4% | 21 |
|
|
2013
Q3 | $4.19M | Buy |
153,690
+12,076
| +9% | +$329K | 0.78% | 40 |
|
|
2013
Q2 | $3.76M | Buy |
+141,614
| New | +$3.91M | 0.7% | 46 |
|
Other funds holding PFE
Cypress Asset Management's PFE Position: Q4 2023 in Review
Cypress Asset Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 13,440 shares — an estimated $439K sold.
Cypress Asset Management first reported a position in PFE in Q2 2013 and held it in 42 quarters. The position peaked at $8.82M in Q2 2016. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- Cypress Asset Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
- Cypress Asset Management sold 13,440 Pfizer shares in Q4 2023, an estimated $439K.
- Cypress Asset Management first reported a position in Pfizer in Q2 2013 and held it in 42 quarters.
- Cypress Asset Management's Pfizer position peaked at $8.82M in Q2 2016.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on Cypress Asset Management's 13F filing for Q4 2023, filed 9 Feb 2024.